Drugs / Bronpass Tab.
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06434792 | Jun 2023 → Sep 2024 | chronic obstructive pulmonary disease | Hanlim Pharm. Co., Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06038084 | Apr → Dec 2022 | bronchitis | Kwang-Ha Yoo | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bronpass Tab. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06038084 ↗ |